Immunic Stock Odds of Future Stock Price Finishing Over 8.61

IMUX -  USA Stock  

USD 8.61  0.25  2.99%

Immunic's future price is the expected price of Immunic instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Immunic performance during a given time horizon utilizing its historical volatility. Price to Book Value is likely to rise to 2.32 in 2021, whereas Price to Earnings Ratio are likely to drop (5.87)  in 2021.

Immunic Price Probability 

 
Refresh
Immunic's implied volatility is one of the determining factors in the pricing options written on Immunic. Implied volatility approximates the future value of Immunic based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Immunic over a specific time period. For example, 2021-11-19 CALL at $7.5 is a CALL option contract on Immunic's common stock with a strick price of 7.5 expiring on 2021-11-19. The contract was last traded on 2021-10-19 at 13:25:59 for $1.5 and, as of today, has 28 days remaining before the expiration. The option is currently trading at a bid price of $1.2, and an ask price of $1.65. The implied volatility as of the 23rd of October is 105.0377. View All Immunic options

Closest to current price Immunic long CALL Option Payoff at Expiration

Please see Immunic Backtesting, Immunic Valuation, Immunic Correlation, Immunic Hype Analysis, Immunic Volatility, Immunic History as well as Immunic Performance. Please specify Immunic time horizon, a valid symbol (red box) and a target price (blue box) you would like Immunic odds to be computed.
Apply Odds

Immunic Target Price Odds to finish over 8.61

The tendency of Immunic Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for foresting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 8.61 90 days 8.61  about 76.89
Based on a normal probability distribution, the odds of Immunic to move above the current price in 90 days from now is about 76.89 (This Immunic probability density function shows the probability of Immunic Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.06 . This usually indicates Immunic market returns are sensitive to returns on the market. As the market goes up or down, Immunic is expected to follow. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Immunic is significantly underperforming DOW.
 Immunic Price Density 
      Price 

Predictive Modules for Immunic

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Immunic. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Immunic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Immunic in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
3.568.3613.16
Details
Intrinsic
Valuation
LowReal ValueHigh
7.5919.3824.18
Details
Naive
Forecast
LowNext ValueHigh
3.007.7912.59
Details
9 Analysts
Consensus
LowTarget PriceHigh
25.0052.5571.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Immunic. Your research has to be compared to or analyzed against Immunic's peers to derive any actionable benefits. When done correctly, Immunic's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Immunic.

Immunic Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Immunic is not an exception. The market had few large corrections towards the Immunic's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Immunic, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Immunic within the framework of very fundamental risk indicators.
α
Alpha over DOW
-0.19
β
Beta against DOW1.06
σ
Overall volatility
0.68
Ir
Information ratio -0.05

Immunic Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Immunic for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Immunic can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Immunic generated a negative expected return over the last 90 days
Immunic has high historical volatility and very poor performance
Immunic was previously known as Vital Therapies and was traded on NMS Exchange under the symbol VTL.
Net Loss for the year was (76.54 M) with loss before overhead, payroll, taxes, and interest of (4.91 K).
Immunic currently holds about 87.17 M in cash with (67.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.32.
Immunic has a very weak financial position based on the latest SEC disclosures
Roughly 25.0% of the company shares are held by company insiders
Latest headline from www.equities.com: Immunic gains 3.34 percent on Moderate Volume October 15 - Equities.com

Immunic Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Immunic Stock often depends not only on the future outlook of the current and potential Immunic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Immunic's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out3.67%
Short Percent Of Float4.11%
Float Shares18.97M
Shares Short Prior Month1.64M
Average Daily Volume Last 10 Day214.08k
Average Daily Volume In Three Month232.77k
Date Short Interest31st of August 2021

Immunic Technical Analysis

Immunic's future price can be derived by breaking down and analyzing its technical indicators over time. Immunic Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Immunic. In general, you should focus on analyzing Immunic Stock price patterns and their correlations with different microeconomic environments and drivers.

Immunic Predictive Forecast Models

Immunic time-series forecasting models is one of many Immunic's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Immunic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Immunic

Checking the ongoing alerts about Immunic for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Immunic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Immunic Alerts

Immunic Alerts and Suggestions

Immunic generated a negative expected return over the last 90 days
Immunic has high historical volatility and very poor performance
Immunic was previously known as Vital Therapies and was traded on NMS Exchange under the symbol VTL.
Net Loss for the year was (76.54 M) with loss before overhead, payroll, taxes, and interest of (4.91 K).
Immunic currently holds about 87.17 M in cash with (67.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.32.
Immunic has a very weak financial position based on the latest SEC disclosures
Roughly 25.0% of the company shares are held by company insiders
Latest headline from www.equities.com: Immunic gains 3.34 percent on Moderate Volume October 15 - Equities.com
Please see Immunic Backtesting, Immunic Valuation, Immunic Correlation, Immunic Hype Analysis, Immunic Volatility, Immunic History as well as Immunic Performance. Note that the Immunic information on this page should be used as a complementary analysis to other Immunic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Immunic Stock analysis

When running Immunic price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
The market value of Immunic is measured differently than its book value, which is the value of Immunic that is recorded on the company's balance sheet. Investors also form their own opinion of Immunic's value that differs from its market value or its book value, called intrinsic value, which is Immunic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunic's market value can be influenced by many factors that don't directly affect Immunic underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunic's value and its price as these two are different measures arrived at by different means. Investors typically determine Immunic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.